Intelligence for the Dealmaking Community since 1965
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
This is premium content

To read the full story, please upgrade your plan.

Upgrade plan
Login to your account

Bass Berry & Sims

image
Honors
Mergers & Acquisitions Names Its 2026 Most Influential Women in Mid-Market M&A
Our 11th annual class honors 13 dealmakers.
January 5, 2026
image
Bankers & Advisors
2026 M﹠A Outlook: Sector Analysis
Dealmakers across nine sectors outline where capital, consolidation and growth will concentrate in 2026.
December 31, 2025
image
Private Equity
Eight Factors That Will Drive More M&A in 2026
After years of stalled exits and valuation gaps, shifting macro tailwinds may finally crack open the PE M&A dam next year.
December 2, 2025
image
Honors
Bass Berry & Sims’ Angela Humphreys Named to the 2025 Most Influential Women in Mid-Market M&A
"I became a founding investor in Athena Ventures, a fund launched by Claritas Capital to specifically fund and grow businesses of women entrepreneurs."
January 6, 2025

Trending

1.
Mergers & Acquisitions Reveals Its 2026 Best Places to Work in Private Equity
September 8, 2026
2.
Aviation Services M&A Takes Off
August 17, 2026
3.
Secondaries Edge: Credit and Fund Finance Converge, Liquidity Comes With Fine Print
September 2, 2026
4.
Secondaries Edge: The Never-Ending Hold
August 19, 2026
5.
Private Credit Shops Hunt Beyond Buyout Finance
August 20, 2026
6.
A New Kind of Serial Acquirer
August 18, 2026
7.
Family Offices Take Control in the Lower Middle Market
August 26, 2026
8.
August M&A Hits New Low, But Dealmakers See Momentum Ahead
September 3, 2026
9.
How Broadwing Found a Way Around the First-Time Fundraising Hurdle
August 21, 2026
image
Healthcare
Peak Rock Capital Buys Asembia
Asembia provides commercialization services for the specialty pharmaceutical industry, serving pharmaceutical manufacturers, pharmacies, prescribers and patients.
July 2, 2026